We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
-11.95%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$270M
AUM Growth
-$91.5M
Cap. Flow
-$47.5M
Cap. Flow %
-17.6%
Top 10 Hldgs %
29.27%
Holding
186
New
6
Increased
34
Reduced
74
Closed
23

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$7.06M
2
UNH icon
UnitedHealth
UNH
+$6.09M
3
ZTS icon
Zoetis
ZTS
+$5.52M
4
ULTA icon
Ulta Beauty
ULTA
+$3.73M
5
VZ icon
Verizon
VZ
+$479K

Top Sells

Rank Stock Value
1
APH icon
Amphenol
APH
+$7.85M
2
PSX icon
Phillips 66
PSX
+$7.78M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$7.68M
4
SCHW
Charles Schwab
SCHW
+$7.42M
5
CTAS icon
Cintas
CTAS
+$7.25M

Sector Composition

Rank Sector Weight
1 Healthcare 24.65%
2 Technology 17.48%
3 Financials 9.53%
4 Industrials 8.75%
5 Consumer Discretionary 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXC icon
151
Exelon
EXC
$47B
$201K 0.07%
+6,235
New +$199K
VALE icon
152
Vale
VALE
$62.6B
$197K 0.07%
14,950
-2,000
-12% -$28.6K
MIN
153
Aberdeen Intermediate Income Fund
MIN
$278M
$174K 0.06%
47,300
-2,000
-4% -$7.37K
NEA icon
154
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.42B
$143K 0.05%
11,618
– –
DTF
155
DTF Tax-Free Income 2028 Term Fund
DTF
$81.1M
$140K 0.05%
11,329
– –
NXQ
156
DELISTED
NUVEEN ELECT TAX-FREE INC 2
NXQ
$140K 0.05%
10,433
– –
SIRI icon
157
SiriusXM
SIRI
$10.1B
$62K 0.02%
1,088
– –
USA icon
158
Liberty All-Star Equity Fund
USA
$1.85B
$60K 0.02%
11,200
– –
TCRT icon
159
Alaunos Therapeutics
TCRT
$4.86M
$37K 0.01%
131
– –
APH icon
160
Amphenol
APH
$209B
– –
-334,108
Closed -$7.85M
CAG icon
161
Conagra Brands
CAG
$7.23B
– –
-17,085
Closed -$580K
CTAS icon
162
Cintas
CTAS
$81.3B
– –
-146,660
Closed -$7.25M
DELL icon
163
Dell
DELL
$293B
– –
-11,021
Closed -$300K
DGX icon
164
Quest Diagnostics
DGX
$26.3B
– –
-47,600
Closed -$5.14M
DOV icon
165
Dover
DOV
$28.4B
– –
-2,493
Closed -$221K
FLR icon
166
Fluor
FLR
$7.96B
– –
-5,190
Closed -$302K
GILD icon
167
Gilead Sciences
GILD
$165B
– –
-3,535
Closed -$273K
GS icon
168
Goldman Sachs
GS
$303B
– –
-21,362
Closed -$4.79M
IFF icon
169
International Flavors & Fragrances
IFF
$21.9B
– –
-1,541
Closed -$214K
IWO icon
170
iShares Russell 2000 Growth ETF
IWO
$15.1B
– –
-1,015
Closed -$218K
KRE icon
171
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
– –
-9,300
Closed -$553K
LMT icon
172
Lockheed Martin
LMT
$136B
– –
-680
Closed -$235K
MU icon
173
Micron Technology
MU
$991B
– –
-4,785
Closed -$216K
PSX icon
174
Phillips 66
PSX
$81.4B
– –
-69,052
Closed -$7.78M
SCHW
175
Charles Schwab
SCHW
$187B
– –
-150,875
Closed -$7.42M
4 5 6
7
8

Similar funds

BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return
MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
CP
Corbenic Partners Bethlehem, Pennsylvania $380M AUM 10.47% 1-Year Est. Return
BWM
BT Wealth Management Atlanta, Georgia $356M AUM 9.63% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
IC
Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return

Dixon Hubard Feinour & Brown's Q4 2018 Portfolio in Review

As of Q4 2018, Dixon Hubard Feinour & Brown held 186 positions worth $270M, down 25% from $362M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Dixon Hubard Feinour & Brown withdrew a net $47.5M in Q4 2018, closing 23 positions and reducing 74 holdings. Its most notable exit was Amphenol, an estimated $7.85M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

Against the trend, Dixon Hubard Feinour & Brown opened a new position in Edwards Lifesciences worth $7.12M.

  • Dixon Hubard Feinour & Brown's largest Q4 2018 buy was Edwards Lifesciences: 139,536 shares worth $7.12M.
  • Dixon Hubard Feinour & Brown added most to UnitedHealth in Q4 2018, an estimated $6.09M increase.
  • Dixon Hubard Feinour & Brown's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $7.68M.
  • Dixon Hubard Feinour & Brown fully exited Amphenol in Q4 2018, selling an estimated $7.85M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 29% of its $270M portfolio in Q4 2018.
  • Dixon Hubard Feinour & Brown opened 6 new positions and closed 23 in Q4 2018.
  • Dixon Hubard Feinour & Brown's portfolio value fell 25% quarter-over-quarter to $270M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q4 2018, filed 13 Feb 2019.